IL95154A - History of cyclosporine, their preparation and pharmaceutical preparations containing them - Google Patents

History of cyclosporine, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL95154A
IL95154A IL9515490A IL9515490A IL95154A IL 95154 A IL95154 A IL 95154A IL 9515490 A IL9515490 A IL 9515490A IL 9515490 A IL9515490 A IL 9515490A IL 95154 A IL95154 A IL 95154A
Authority
IL
Israel
Prior art keywords
residue
cyclosporin
formula
cyclosporins
product
Prior art date
Application number
IL9515490A
Other languages
English (en)
Hebrew (he)
Other versions
IL95154A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL95154A0 publication Critical patent/IL95154A0/xx
Publication of IL95154A publication Critical patent/IL95154A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9515490A 1989-07-24 1990-07-23 History of cyclosporine, their preparation and pharmaceutical preparations containing them IL95154A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916901A GB8916901D0 (en) 1989-07-24 1989-07-24 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
IL95154A0 IL95154A0 (en) 1991-06-10
IL95154A true IL95154A (en) 1995-03-30

Family

ID=10660543

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9515490A IL95154A (en) 1989-07-24 1990-07-23 History of cyclosporine, their preparation and pharmaceutical preparations containing them

Country Status (23)

Country Link
EP (1) EP0414632B1 (fr)
JP (1) JPH0730113B2 (fr)
KR (1) KR100201174B1 (fr)
AT (1) ATE144536T1 (fr)
AU (1) AU631667B2 (fr)
CA (1) CA2021788C (fr)
CZ (1) CZ411691A3 (fr)
DE (1) DE69028967T2 (fr)
DK (1) DK0414632T3 (fr)
ES (1) ES2092500T3 (fr)
FI (1) FI94355C (fr)
GB (1) GB8916901D0 (fr)
GR (1) GR3021667T3 (fr)
HK (1) HK1004268A1 (fr)
HU (1) HU206127B (fr)
IE (1) IE902669A1 (fr)
IL (1) IL95154A (fr)
MY (1) MY105942A (fr)
NZ (1) NZ234613A (fr)
PT (1) PT94790B (fr)
SA (1) SA91110205B1 (fr)
SK (1) SK411691A3 (fr)
ZA (1) ZA905823B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
GB9204466D0 (en) * 1992-03-02 1992-04-15 Sandoz Ltd Improvements in or relating to organic compounds
US5482850A (en) * 1993-10-29 1996-01-09 New England Biolabs, Inc. Method for identifying anti-parasitic compounds
WO1997011092A1 (fr) * 1994-04-07 1997-03-27 Nippon Shinyaku Co., Ltd. Derives de phosphates de cyclosporine et composition medicinale
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100465012B1 (ko) 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
SI1436321T1 (sl) 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina
KR100865211B1 (ko) * 2001-10-26 2008-10-23 주식회사 엘지생활건강 비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en) 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
KR100439467B1 (ko) * 2002-11-13 2004-07-09 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
WO2008069917A2 (fr) 2006-11-20 2008-06-12 Scynexis, Inc. Nouveaux peptides cycliques
EP2780358B1 (fr) * 2011-11-15 2016-03-23 Allergan, Inc. Forme 2 de la cyclosporine et procédé pour sa préparation
WO2020037530A1 (fr) 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Forme cristalline d'un composé et ses utilisations en médecine
WO2020122182A1 (fr) * 2018-12-12 2020-06-18 中外製薬株式会社 Acide aminé ayant un groupe fonctionnel capable de former une liaison hydrogène intermoléculaire, composé peptidique le contenant et son procédé de production

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (fr) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
EP0034567B1 (fr) 1980-02-14 1984-11-07 Sandoz Ag Procédé de synthèse totale des cyclosporines ainsi que les nouvelles cyclosporines
EP0056782B1 (fr) 1981-01-09 1984-08-01 Sandoz Ag Cyclosporines
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0198026B1 (fr) 1984-10-04 1993-08-04 Sandoz Ag Anticorps monoclonaux contre les cyclosporines
US4798823A (en) 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
GB2206119B (en) 1987-06-22 1990-10-31 Merck & Co Inc A new cyclosporin derivative with modified "8-amino acid"
GB8717299D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Peptides
GB8717300D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
GB2207678A (en) 1987-08-03 1989-02-08 Merck & Co Inc Novel immunosuppressive fluorinated cyclosporin analogs
HU205010B (en) 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins

Also Published As

Publication number Publication date
GR3021667T3 (en) 1997-02-28
DE69028967D1 (de) 1996-11-28
DK0414632T3 (da) 1996-11-25
ZA905823B (en) 1992-03-25
HU206127B (en) 1992-08-28
IE902669A1 (en) 1991-02-27
JPH03218396A (ja) 1991-09-25
EP0414632B1 (fr) 1996-10-23
ATE144536T1 (de) 1996-11-15
KR100201174B1 (ko) 1999-06-15
HU904224D0 (en) 1990-12-28
PT94790B (pt) 1997-04-30
MY105942A (en) 1995-02-28
AU631667B2 (en) 1992-12-03
CZ411691A3 (cs) 1998-06-17
SA91110205B1 (ar) 2004-08-07
CA2021788A1 (fr) 1991-01-25
DE69028967T2 (de) 1997-05-15
HK1004268A1 (en) 1998-11-20
EP0414632A3 (en) 1991-09-11
GB8916901D0 (en) 1989-09-06
FI903706A0 (fi) 1990-07-23
CA2021788C (fr) 2001-02-13
AU5972790A (en) 1991-01-24
SK411691A3 (en) 1995-07-11
FI94355B (fi) 1995-05-15
KR910002902A (ko) 1991-02-26
EP0414632A2 (fr) 1991-02-27
FI94355C (fi) 1995-08-25
HUT54714A (en) 1991-03-28
NZ234613A (en) 1992-09-25
ES2092500T3 (es) 1996-12-01
JPH0730113B2 (ja) 1995-04-05
PT94790A (pt) 1991-03-20
IL95154A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
US5284826A (en) 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins
EP0414632B1 (fr) Dérivés de cyclosporine
US6809077B2 (en) Cyclosporin analogs for the treatment of autoimmune diseases
US4914188A (en) Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US6979671B2 (en) Cyclosporins for the treatment of immune disorders
US5525590A (en) Cyclosporins and their use as pharmaceuticals
US5227467A (en) Immunosuppressive fluorinated cyclosporin analogs
US7012065B2 (en) Cyclosporins for the treatment of immune disorders
US7012064B2 (en) Cyclosporins for the treatment of immune disorders
US4639434A (en) Novel cyclosporins
US4764503A (en) Novel cyclosporins
EP0444897A1 (fr) Nouvelles analogues immunosuppressives de la cyclosporine avec des acides aminées modifiées dans la position 8
EP0373260B1 (fr) Dérivés de cyclosporine avec un acide aminé modifié en position 8
US20040110666A1 (en) Cyclosporins for the treatment of immune disorders
GB2207678A (en) Novel immunosuppressive fluorinated cyclosporin analogs
WO1999062540A1 (fr) Utilisation de cyclosporines pour traiter les maladies inflammatoires auto-immunes
WO1993017039A1 (fr) Sels d'iso-cyclosporine
AU596071B2 (en) Novel cyclosporins
PL164131B1 (pl) Sposób wytwarzania nowej cyklosporyny
GB2227244A (en) Immunosuppressive fluorinated cyclosporin analogs
JPH0338280B2 (fr)
JPH0717677B2 (ja) “８−アミノ酸”に改良のある新規シクロスポリン誘導体

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees